Tefferi, A., Gangat, N., Shah, M., Alkhateeb, H., Patnaik, M. S., Al-Kali, A., Elliott, M. A., Hogan, W. J., Litzow, M. R., Hook, C. C., Mangaonkar, A., Viswanatha, D., Chen, D., Pardanani, A., Ketterling, R. P. and Begna, K. H. (2022) “Daunorubicin-60 versus daunorubicin-90 versus idarubicin-12 for induction chemotherapy in acute myeloid leukemia: a retrospective analysis of the Mayo Clinic experience”, Haematologica. Pavia, Italy, 107(10), pp. 2474-2479. doi: 10.3324/haematol.2022.281045.